Skip to Main Content

Paper Details

In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors.
Blood Cancer J
5
2022
MM, MM cells, NPC, PCB1 binding motifs, RNA, SFs, SRSF1, SRSF1, SRSF9, and PCB1 binding motifs, SRSF9, alternatively spliced genes, cancer, gene symbols, multiple myeloma, mutually exclusive exons, normal plasma cells, patients, tumor, tumor cell
Author NameAffiliation
Kenneth C AndersonDana Farber Cancer Institute, Harvard Medical School
Kenneth C AndersonDana Farber Cancer Institute, Harvard Medical School
Giovanni ParmigianiDana Farber Cancer Institute
Giovanni ParmigianiHarvard T.H. Chan School of Public Health Boston
Giovanni ParmigianiDana Farber Cancer Institute
Giovanni ParmigianiHarvard T.H. Chan School of Public Health Boston
  • 1 - 6

Datasets

Release 1.2